Press release
Continuous Glucose Monitoring Market to Remain Lucrative During 2019
Continuous glucose monitoring, better known as CGMS, refers to the real-time monitoring of glucose levels at regular intervals with the help of portable glucose monitoring systems. The glucose level in the human body is also determined by blood glucose meters but they measure the glucose level in the blood. With the help of wireless technology, portable blood glucose monitoring devices transmit glucose readings collected from the interstitial fluid between skin cells.
View and Download TOC of Continuous Glucose Monitoring Market Research Report@ https://www.transparencymarketresearch.com/report-toc/1169
The report points out that the rise in the diabetic population worldwide has majorly boosted the demand for continuous glucose monitoring devices. According to the International Diabetes Federation (IDF), around 382 mn people were diagnosed with diabetes across the globe in 2013. By 2035, the total number of diabetics over the world is expected to reach a staggering 592 mn.
Type I diabetes is the most common form of diabetes among adults. In the U.K., about 10% of the total diabetic population suffers from type I diabetes. Continuous glucose monitoring systems have been identified as the most effective tools for management of type I diabetes, where patients are insulin-dependent. However, unfavorable reimbursement policies might restrict the growth of the global continuous glucose monitoring market during the forecast horizon. The overall market has a huge scope to grow with the development of continuous glucose monitoring devices based on non-invasive techniques.
On the basis of device, the report segments the global continuous glucose monitoring devices market into Dexcom Seven Plus CGM System, FreeStyle Navigator, Guardian Real Time CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/ Veo Systems, and others. In 2012, the Guardian Real Time CGM System dominated the overall market, followed by Dexcom Seven Plus CGM System.
Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1169
The report studies the continuous glucose monitoring market across four key regions: Asia Pacific, Europe, North America, and Rest of the World. North America dominated the overall market in 2012 owing to the rapidly growing obese population, technical advancements in medical equipment, and rise in geriatric population. During the forecast horizon, Asia Pacific is anticipated to register rapid growth. Changes in lifestyle, increasing patient awareness, and economic development will fuel the demand for continuous glucose monitoring devices.
The report profiles some of the key players in the global continuous glucose monitoring market such as Dexcom Inc., Medtronic Inc., Abbott Laboratories Inc., GlySens Incorporated Nova Biomedical Corporation, Bayer AG, Senseonics Incorporated, and Insulet Corporation. The report provides information about the product portfolio, financial overview, recent developments, and business strategies adopted by the companies to ensure sustainability and maximize profits.
Buy Full Continuous Glucose Monitoring Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=1169<ype=S
About TMR
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Continuous Glucose Monitoring Market to Remain Lucrative During 2019 here
News-ID: 736000 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Continuous
Continuous Integration and Continuous Delivery Solutions Market Scope and overvi …
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Continuous Integration and Continuous Delivery Solutions market will undergo major changes. According to the latest research, the market size of the Continuous Integration and Continuous Delivery Solutions industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Continuous Integration and Continuous Delivery Solutions industry report provides…
Continuous Integration (CI) Tools Market Continuous Excellent Growth | AutoRABIT …
The most up-to-date market exploration report on the Continuous Integration (CI) Tools Market performs industry diagnostic as a way to accumulate valuable data into the business environment of the Continuous Integration (CI) Tools Market for the forecast period 2020-2026.
The subject matter experts behind the research have collected vital statistics on the market share, size and growth as a way to help stakeholders, business owners and field marketing personnel identify the…
Continuous Renal Replacement Therapy (CRRT) Market Report 2018: Segmentation by …
Global Continuous Renal Replacement Therapy (CRRT) market research report provides company profile for Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Bellco, NxStage Medical, Inc., Nipro Corporation, NIKKISO CO., LTD., Toray Medical Company Limited, INFOMED SA and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018…
Continuous ‘everything‘ in practice
Moehrendorf, 2 October 2018 – Speed is becoming the key success factor in software development. Continuous integration, delivery and deployment need, however, the corresponding knowledge and the right tools. The Software-QS-Tag 2018 presents both.
Also this year the leading conference about software quality assurance and testing in the German-speaking area is accompanied by a technical exhibition. On the whole, 18 associations, service providers, tool suppliers and publishing houses present their solutions…
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market.
The global CGM market is undergoing a…
Continuous Glucose Monitoring Systems Europe Market Is Expected High Growth in N …
Research Beam added report on “Europe Continuous Glucose Monitoring Systems Market Technology, Trends, Growth and Research – Europe Continuous Glucose Monitoring Systems Market by Component (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (14 years), and Adult Population (>14 years)), and End User (Diagnostic Centers/Clinics, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2014-2022”
Research Beam study says Europe continuous glucose monitoring systems market accounted…
